During the one-year follow-up observation, continued use of anti-TNF therapy did not increase HIV-RNA levels, CD4+ lymphocyte counts remained stable, and showed a possibility of slowing down the progression of HIV infection. This evidence concerns the gene TNF and HIV infectious disease.